PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced it has received the CE mark for its flagship medical devices, enabling commercialization of the B-Right AI Platform across the European Union. The company will make its European debut at the Fetal Medicine Foundation (FMF) World Congress in Vienna, Austria, at the end of June 2026. Fetal ultrasound is among the most technically demanding imaging examinations in clinical practice, requiring the